Sandia Investment Management »

4d Molecular Therapeutics In shares owned by Sandia Investment Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Sandia Investment Management from 13F filings

Historical chart of Sandia Investment Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Sandia Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Sandia Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $91k 4.5k 20.26
2023-09-30 $96k 7.5k 12.73
2023-06-30 $136k 7.5k 18.07

More positions owned by Sandia Investment Management

Sdcl Edge Acquisition Corp Cl A Ord Shs (SEDA)
Lavoro Class A Ord (LVRO)
Screaming Eagle Acquisitn Unit 01/05/2027 (SCRMU)
Haymaker Acquisition Corp Iv Unit 99/99/9999 (HYAC.U)
Dmy Squared Technology Group Cl A Com (DMYY)
Southport Acquisition Corp Cl A Com (PORT)
Sk Growth Opportunities Corp Class A Com (SKGR)
Nkgen Biotech (NKGN)
Concord Acquisition Corp Ii Com Cl A (CNDA)
Gores Holdings Ix Unit 01/14/2029 (GHIXU)
Churchill Capital Corp Vii Com Cl A (CVII)
Screaming Eagle Acquisitn Class A Ord Shs (SCRM)
Heico Corp Cl A (HEI.A)
Tortoiseecofin Acquisition C Shs Cl A (TRTL)
Battery Future Acquisition C Cl A Ord Shs (BFAC)

View all positions for Sandia Investment Management

Top funds holding 4d Molecular Therapeutics In

Viking Global Investors
RA Capital Management
BVF
VR Adviser
Henderson Group
Vanguard Group
Arrowpoint Asset Management
Casdin Capital
Goldman Sachs Group
Dimensional Fund Advisors
Deutsche Bank Aktiengesellschaft
Eagle Health Investments
Assenagon Asset Management
Jpmorgan Chase & Co
Point72 Asset Management

View all funds holding 4d Molecular Therapeutics In